Recombinant Human CD358/DR6/TNFRSF21 Protein
Recombinant Human CD358/DR6/TNFRSF21 Protein (RP00899-GRP)
Products
Description
Recombinant Human CD358/DR6/TNFRSF21 Protein is produced by Human cells expression system. The target protein is expressed with sequence (Gln42-Leu350) of human CD358/DR6/TNFRSF21 (Accession #O75509) fused with an Fc tag at the C-terminus.
Specifications
| Manufacturer | Abclonal Biotechnology |
|---|---|
| Manufacturer Cat# | RP00899 |
| Bio-Activity | Measured by its binding ability in a functional ELISA. When recombinant human APP770 is coated at 2 μg/mL (100 μL/well), the concentration of Recombinant Human CD358/DR6/TNFRSF21 that produces 50% of the optimal binding response is found to be approximately 20-100 ng/mL. |
| Alternate Names | Tumor Necrosis Factor Receptor Superfamily Member 21; Death Receptor 6; CD358; TNFRSF21; DR6; UNQ437/PRO868 |
| Reactivity | Human |
| Gene ID | 27242 |
| Swiss Prot | O75509 |
| Storage | -80℃ |